For the Clinician Who Needs More Than a Label
When a pediatric practitioner recommends a supplement to a family, they are doing more than suggesting a product. They are extending their professional credibility. That is not a small thing. It is why so many clinicians—regardless of their openness to nutritional interventions—approach the supplement space with caution. The standards of evidence are inconsistent, the ingredient sourcing is often opaque, and the third-party testing, when it exists at all, is rarely comprehensive.
Agebox™ was designed with this clinical reality in mind. Its Practitioner Program, now active with more than 6,000 healthcare providers globally, is structured around a single premise: practitioners should never have to recommend something they cannot fully interrogate.
The Agebox Safety Framework
Agebox’s approach to product safety begins upstream, at the point of ingredient selection—where the Acesvia™ platform’s bioactive purification process systematically removes inactive and potentially interfering compounds before any formula reaches production. But the company does not ask practitioners or families to take that process on faith.
Every new batch of Agebox products undergoes independent third-party testing across four risk categories of particular relevance to pediatric nutrition. Several panels in this framework—including growth hormone secretagogue screening—reflect the company’s proactive decision to test beyond standard industry requirements, ensuring that every batch meets the same rigorous benchmarks.
Heavy metals (lead, arsenic, mercury, chromium, cadmium): independently tested by SGS against strict purity limits. All results within compliance benchmarks.
Hormonal adulterants (androgens, progestogens, estrogens, glucocorticoids—35 compounds in total): independently tested by SGS at zero-tolerance thresholds (LOQ 50 μg/kg). None detected.
